Search Results
Dr. John Byrd Summarizes the RESONATE Study Findings
Dr. Byrd on Updated RESONATE Findings in CLL
Personalized AML therapy with John Byrd: the beat AML trial and more
Dr. John Byrd on Challenges in CLL
Dr. John Byrd Discusses the Treatment Landscape for CLL
Dr. Woyach Discusses Efficacy Findings from the RESONATE Trial
John C. Byrd, et al.
Dr. Byrd Describes a Phase I/Ib Study of the CDK Inhibitor Dinaciclib in CLL
Beat AML: John Byrd, M.D., OSUCCC
Dr. Woyach Discusses the Efficacy Findings from the RESONATE Trial
ASH 2012: Dr John Byrd Part 1 TKIs and the Dream of Magic Bullets: The Story of BCR blockers
Overview of RESONATE-2 clinical trial of ibrutinib in CLL
